课题基金 / 基金详情

Molecular Mechanism of Barrier Function Changes of Epithelial Tight Junction in Allergic Rhinitis

Molecular Mechanism of Barrier Function Changes of Epithelial Tight Junction in Allergic Rhinitis
变应性鼻炎上皮紧密连接屏障功能变化的分子机制
批准号:
12671660
负责人:
TAKEUCHI Kazuhiko
金额:
$1.73万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

TAKEUCHI Kazuhiko的其他基金

相似基金

相关文献

中文摘要
翻译
1.我们使用Calu-3细胞系检测了组胺、白三烯D4(LTD 4)和凝血酶对上皮细胞对14 C标记的甘露醇和白蛋白的通透性的影响。10 μ <-6>M LTD 4不改变对甘露醇或白蛋白的渗透性。另一方面,组胺和10 <-7>μ M<-8>凝血酶显著增加上皮细胞对甘露醇的渗透性。此外,10 μ <-4>M组胺可显著增加辣根过氧化物酶穿过豚鼠鼻上皮紧密连接的通道.接下来,我们研究了组胺和凝血酶是否可以改变紧密连接蛋白的mRNA表达。我们将组胺或赋形剂加入培养的人鼻上皮细胞中,并在4小时后从它们中提取RNA。DNA酶处理后,RT-PCR扩增β-actin和ZO-1紧密连接蛋白的mRNA。组胺显著下调ZO-1 mRNA表达。这种作用被阻断预处理与美托洛尔,H1受体拮抗剂。接下来,我们检测了凝血酶对培养的上皮细胞中紧密连接蛋白mRNA表达的影响。凝血酶显著降低细胞ZO-1 mRNA的表达,但对occludin或claudin mRNA的表达没有影响。组胺和凝血酶导致ZO-1 mRNA减少可能导致鼻过敏反应期间粘膜通透性增加。
英文摘要
1. We examined the effect of histamine, leukotriene D4 (LTD4) and thrombin on the epithelial permeability to 14C labeled mannitol and albumin using Calu-3 cell lines. 10^<-6>M LTD4 did not change permeability to mannitol or albumin. On the other hand, histamine and 10^<-7>〜10^<-8> M thrombin significantly increased epithelial permeability to mannitol. Moreover, 10^<-4>M histamine significantly increased the passage of horseradish peroxidase across epithelial tight junction in guinea pig nose.2. Next we examined if histamine and thrombin can alter mRNA expression of tight junction proteins. We added histamine or vehicle to cultured human nasal epithelial cells and extracted RNA from them 4 hours later. After DNase treatment, mRNAs of β-actin and ZO-1 tight-junction protein were amplified by RT-PCR. Histamine significantly downregulated ZO-1 mRNA expression. This effect was blocked by pretreatment with mepyramine, an H1 receptor antagonist. Next we examined the effect of thrombin on the tight junction proteins mRNAs expression in cultured epithelial cells. Thrombin significantly decreased ZO-1 mRNA expression of the cells, but had no effect on the expression of occludin or claudin mRNAs. The reduction of ZO-1 mRNA by histamine and thrombin may cause increased permeability of the mucosa during allergic reactions in the nose.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Kazuhiko Takeuchi, et al.: "Histamine Alters Gene Expression in Cultured Human Nasal Epithelial Cells"J Allergy Clin Immunol. 107(2). 310-314 (2001)
Kazuhiko Takeuchi 等人:“组胺改变培养的人鼻上皮细胞中的基因表达”J Allergy Clin Immunol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kazuhiko Takeuchi, et al: "Histamine Alters Gene Expression in Cultured Human Nasal Epithelial Cells"J Allergy Clin Immunol. (in press).
Kazuhiko Takeuchi 等人:“组胺改变培养的人鼻上皮细胞中的基因表达”J Allergy Clin Immunol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kazuhiko Takeuchi, et al.: "Histamine Alters Gene Expression in Cultured Human Nasal Epithelial Cells"J Allergy Clin Immunol. 107. 310-314 (2001)
Kazuhiko Takeuchi 等人:“组胺改变培养的人鼻上皮细胞中的基因表达”J Allergy Clin Immunol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Analysis of the disease causing genes of primary ciliary dyskinesia by gene panel and whole exosome analysis
  • 批准号:
    19K09886
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.75万
  • 财政年份:
    2019
  • 负责人:
    TAKEUCHI Kazuhiko
  • 依托单位:
Research in the improvement in diagnostic accuracy for primary ciliary dyskinesia
  • 批准号:
    25462662
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.24万
  • 财政年份:
    2013
  • 负责人:
    TAKEUCHI Kazuhiko
  • 依托单位:
Elucidation and control of mechanisms of mucus hypersecretion in the intractable upper airway diseases
  • 批准号:
    22591899
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.83万
  • 财政年份:
    2010
  • 负责人:
    TAKEUCHI Kazuhiko
  • 依托单位:
Establishment of novel evaluation methods to measure endothelial functions as a clinical pharmacological tool
  • 批准号:
    22590499
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2010
  • 负责人:
    TAKEUCHI Kazuhiko
  • 依托单位:
国内基金
海外基金
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
  • 批准号:
    82370976
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    郑凌艳
  • 依托单位: